Australia markets closed

Spero Therapeutics Inc (2HA.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
1.2960+0.0080 (+0.62%)
At close: 05:56PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-102,426
22,806
-46,415
-89,756
-78,280
-
Depreciation & amortisation
931
367
869
646
761
-
Stock-based compensation
9,554
7,932
9,123
9,430
4,888
-
Change in working capital
4,260
-70,375
22,087
12,862
-13,392
-
Accounts payable
-577
761
-484
-53
-2,975
-
Other working capital
-79,562
-32,995
-7,731
-64,347
-86,029
-
Other non-cash items
4,812
969
3,283
2,411
513
-
Net cash provided by operating activities
-79,562
-32,995
-7,731
-64,347
-85,872
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-
-157
-314
Purchases of investments
-57,284
0
-26,970
-43,915
-45,723
-
Sales/maturities of investments
67,777
0
60,777
51,548
56,350
-
Other investing activities
-
-
-
39
-
-
Net cash used for investing activities
10,532
0
33,807
7,672
10,470
-
Cash flows from financing activities
Common stock issued
12,808
221
24,512
35,368
78,660
-
Other financing activities
-6,842
-
-54,485
47,232
-953
-158
Net cash used provided by (used for) financing activities
6,617
221
-29,553
84,050
130,881
-
Net change in cash
-62,413
-32,774
-3,477
27,375
55,479
-
Cash at beginning of period
112,859
109,107
112,584
85,209
29,730
-
Cash at end of period
50,446
76,333
109,107
112,584
85,209
-
Free cash flow
Operating cash flow
-79,562
-32,995
-7,731
-64,347
-85,872
-
Capital expenditure
-
-
-
-
-157
-314
Free cash flow
-79,562
-32,995
-7,731
-64,347
-86,029
-